The Cardiovascular Impact of COVID-19

The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system. Risk of severe infection and mortality increase with advancing age and male sex. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia , cardiac injury, fulminant myocarditis, heart failure, pulmonary embolism, and disseminated intravascular coagulation (DIC).

 

 

  • Cardiac stress test
  • Cardiac ventriculography
  • Positron emission photography
  • Tilt table test
  • Radionucleide angiography
  • Phonocardiogram
  • Computed tomography angiography

Related Conference of The Cardiovascular Impact of COVID-19

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
September 19-20, 2024

7th World Heart and Brain Conference

London, UK
September 19-20, 2024

6th Annual Conference on Vascular Medicine

London, UK
October 17-18, 2024

8th Annual Heart Rhythm Conference

Barcelona, Spain
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in